SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-022359
Filing Date
2023-06-26
Accepted
2023-06-26 09:15:35
Documents
41
Period of Report
2023-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38699
2 form8-k_001.jpg GRAPHIC 5681
3 ex99-1.htm EX-99.1 37145
4 ex99-1_001.jpg GRAPHIC 339790
5 ex99-1_002.jpg GRAPHIC 337265
6 ex99-1_003.jpg GRAPHIC 281119
7 ex99-1_004.jpg GRAPHIC 302505
8 ex99-1_005.jpg GRAPHIC 287272
9 ex99-1_006.jpg GRAPHIC 188273
10 ex99-1_007.jpg GRAPHIC 202048
11 ex99-1_008.jpg GRAPHIC 179125
12 ex99-1_009.jpg GRAPHIC 353645
13 ex99-1_010.jpg GRAPHIC 365764
14 ex99-1_011.jpg GRAPHIC 303104
15 ex99-1_012.jpg GRAPHIC 326501
16 ex99-1_013.jpg GRAPHIC 322697
17 ex99-1_014.jpg GRAPHIC 230722
18 ex99-1_015.jpg GRAPHIC 186443
19 ex99-1_016.jpg GRAPHIC 202210
20 ex99-1_017.jpg GRAPHIC 257391
21 ex99-1_018.jpg GRAPHIC 261960
22 ex99-1_019.jpg GRAPHIC 220164
23 ex99-1_020.jpg GRAPHIC 279795
24 ex99-1_021.jpg GRAPHIC 250026
25 ex99-1_022.jpg GRAPHIC 174287
26 ex99-1_023.jpg GRAPHIC 287652
27 ex99-1_024.jpg GRAPHIC 291304
28 ex99-1_025.jpg GRAPHIC 197605
29 ex99-1_026.jpg GRAPHIC 170228
30 ex99-1_027.jpg GRAPHIC 362249
  Complete submission text file 0001493152-23-022359.txt   10131053

Data Files

Seq Description Document Type Size
31 XBRL SCHEMA FILE lpcn-20230626.xsd EX-101.SCH 3283
32 XBRL LABEL FILE lpcn-20230626_lab.xml EX-101.LAB 34240
33 XBRL PRESENTATION FILE lpcn-20230626_pre.xml EX-101.PRE 22359
35 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3317
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 231039594
SIC: 2834 Pharmaceutical Preparations